June 9, 2003 |
Defense attorney J. Michael Nolan hasn't seen a witness list and he isn't familiar with the physical evidence or other details of the government's case, but he already knows what his final words to the jury would be: "If it wasn't Martha Stewart, do you think we'd be here?" That's the money line, and if Nolan were defending Martha Stewart, he'd build his whole case around it.
June 13, 2002 |
Bristol-Myers Squibb Co. executive Brian Markison will be asked today about how he learned four days beforehand that regulators would reject a cancer drug developed by ImClone Systems Inc., Bristol-Myers' partner, said the chairman of the panel holding the hearing. The Food and Drug Administration on Dec. 28 rejected ImClone's application for Erbitux. Four days earlier, a FDA employee told a Bristol-Myers attorney Dec. 24 that the agency found the application flawed, said Rep. James C.
March 6, 2004 |
In a sweeping victory for the government, a federal jury Friday found Martha Stewart guilty of conspiracy, obstruction of justice and two counts of lying to investigators, a verdict that means the media entrepreneur almost certainly will serve prison time. Stewart, 62, who built a business empire on her sense of style in food, decorating and entertaining, is the first major figure convicted by a jury in the wave of corporate scandals involving such now-notorious names as Enron Corp.
October 15, 2002 |
Samuel D. Waksal, the founder and former CEO of ImClone Systems Inc. and a friend of Martha Stewart, is expected to plead guilty today to multiple charges in the company's insider trading case, a law enforcement source told the Associated Press on Monday. Waksal faces federal charges of securities fraud, perjury, bank fraud and obstruction of justice. The source, who requested anonymity, would not say to which charges Waksal was to plead guilty.
October 11, 2003 |
The insider trading case involving former ImClone Systems Inc. Chief Executive Samuel D. Waksal and Martha Stewart has widened to include Waksal's father and sister. The Securities and Exchange Commission on Friday sued Jack Waksal, 82, in an amended complaint originally filed against Samuel Waksal. The new charges also name Samuel Waksal's sister, Patti, 47, as a relief defendant, who did not break the law but benefited from actions of her father.
June 11, 2003 |
Samuel D. Waksal, the fallen founder of drug maker ImClone Systems Inc., was sentenced Tuesday to more than seven years in prison and fined $4.3 million by a federal judge who called Waksal's insider trading abuses "truly incalculable." Waksal is the first prominent U.S. chief executive to be sentenced to prison in the corporate scandals that erupted after Enron Corp. collapsed in 2001. The ImClone affair also has entangled Martha Stewart, a close friend of Waksal's.